Related Experiment Video
Updated: Jan 10, 2026

Isolation and Transplantation of Hematopoietic Stem Cells HSCs
Published on: February 25, 2007
Central Venous Catheter Removal After Hematopoietic Stem Cell Transplant: A Review and Perspective
Eleanor Cook1,2, Seth J Rotz3, Jeffery J Auletta4,5
1Kids Cancer Centre, Sydney Children's Hospital, Sydney, New South Wales, Australia.
Insights
Central venous catheters (CVCs) are vital for hematopoietic stem cell transplantation (HSCT) but prolonged use risks complications. Standardized guidelines are needed for optimal CVC removal timing in HSCT patients.
Area of Science:
- Hematology
- Transplant Medicine
- Vascular Access Devices
Background:
- Central venous catheters (CVCs) are critical for hematopoietic stem cell transplantation (HSCT), enabling drug delivery and nutritional support.
- Prolonged CVC use in HSCT patients is associated with significant complications, including infections, thrombosis, and mechanical issues.
- Current practices for CVC removal timing post-HSCT lack standardization, leading to variability in patient care.
Purpose of the Study:
- To review the literature on central venous catheter management following HSCT.
- To identify factors influencing the timing of CVC removal in HSCT patients.
- To highlight the need for standardized protocols and further research in CVC management post-HSCT.
Main Methods:
- This study conducted a narrative review of existing literature.
- The review focused on CVC management and removal timing in the context of HSCT.
- Key factors influencing removal timing were examined based on patient, disease, and institutional characteristics.
Main Results:
- The timing of CVC removal post-HSCT is highly variable across different healthcare institutions.
- Patient characteristics, disease-specific factors, and institutional practices significantly influence CVC removal decisions.
- There is a lack of standardized guidelines to effectively balance the benefits of CVC access against the risks of prolonged use.
Conclusions:
- Standardized protocols and multi-institutional research are urgently required for optimal CVC management in HSCT.
- Improving CVC removal timing can reduce complications and enhance patient outcomes in HSCT.
- Evidence-based guidelines are essential to optimize the use of CVCs in hematopoietic stem cell transplantation.
Abstract:
Central venous catheters (CVCs) are a cornerstone of hematopoietic stem cell transplantation (HSCT), facilitating the delivery of chemotherapy, parenteral nutrition, medications, and blood products. Despite CVCs' essential role, prolonged use can lead to complications such as increased risk of infection, thrombosis, mechanical issues, and psychosocial burden. However, the timing of CVC removal remains highly variable across institutions. Additionally, there are no standardized guidelines to balance the benefits of extended access against the risks of prolonged use. This narrative review examines the existing literature on CVC management post-HSCT, highlighting key factors influencing the removal timing, such as patient characteristics, disease-specific considerations, and institutional practices. The review emphasizes the urgent need for multi-institutional research and standardized protocols to improve outcomes, reduce complications, and enhance the quality of care for HSCT patients.
More Related Videos
Related Concept Videos
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Hemodialysis II: Procedure and Complications
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Kidney Transplant III: Nursing Management

